Eblin Kylee E, Bredfeldt Tiffany G, Buffington Sarah, Gandolfi A Jay
Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, USA.
Toxicol Sci. 2007 Feb;95(2):321-30. doi: 10.1093/toxsci/kfl160. Epub 2006 Nov 8.
Previous studies have shown that human bladder cells (UROtsa), a target of arsenic-induced cancer, can biotransform arsenite to monomethylarsonous acid (MMA(III)), which is more cytotoxic and capable of transforming the UROtsa cells following long-term, low-level exposure. Cyclooxygenase-2 (COX-2) causes hyperplasia in bladder cells and is considered a key biomarker in bladder cancer. To investigate the role of mitogenic pathway stimulation in MMA(III)-induced transformation, UROtsa cells were treated with 50nM MMA(III) for 12, 24, or 52 weeks and analyzed by Western blot for COX-2 expression. Elevations in COX-2 expression were noted following chronic MMA(III) exposure, and this induction increased with duration of exposure, suggesting that COX-2 or the signal transduction pathways responsible for COX-2 protein expression may play a role in MMA(III)-induced transformation. Acute exposure studies found MMA(III) treatment (10, 50, and 100nM, 4 h) induced COX-2 in UROtsa cells with the lowest doses (10 and 50nM) causing the strongest induction. Using pharmacological inhibitors of various pathways, it was shown that epidermal growth factor receptor (EGFR), extracellular signal-regulated kinase (ERK-1/-2), phosphoinositide 3-kinase (PI3K), and src were important in the induction of COX-2 by MMA(III). ERK-2 phosphorylation was verified by Western blot analysis with a peak at 15 min, and c-jun was translocated to the nucleus following 50nM MMA(III) treatment. To determine MMA(III) targets, receptors of the erythroblastosis oncogene family (ErbB) family were further investigated. Chronic MMA(III) exposure led to upregulation of the EGFR or ErbB1. Short-term MMA(III) treatment caused the phosphorylation of ErbB2 in its autophosphorylation site. To verify the importance of these signaling pathways to the growth of the MMA(III)-transformed UROtsa cells in soft agar, various inhibitors were used to block pathways and monitor cells growth. Pathways of importance in anchorage-independent growth of UROtsa cells chronically exposed to MMA(III) are src, PI3K, and COX-1 and -2. As COX-2 is an important mediator that contributes to carcinogenesis via promotion of cell proliferation, inhibition of cell death, induction of angiogenesis, and facilitation of invasion, and it is highly upregulated both acutely and chronically in the MMA(III)-transformed cells, it is likely that activation of the mitogen-activated protein kinase pathway and increased COX-2 expression is a plausible mechanism for MMA(III) bladder carcinogenesis.
先前的研究表明,人膀胱细胞(UROtsa)是砷诱导癌症的靶细胞,它可将亚砷酸盐生物转化为一甲基亚胂酸(MMA(III)),MMA(III)的细胞毒性更强,在长期低水平暴露后能够使UROtsa细胞发生转化。环氧化酶-2(COX-2)可导致膀胱细胞增生,被认为是膀胱癌的关键生物标志物。为了研究有丝分裂原途径刺激在MMA(III)诱导的转化中的作用,将UROtsa细胞用50nM MMA(III)处理12、24或52周,然后通过蛋白质免疫印迹法分析COX-2的表达。长期暴露于MMA(III)后,COX-2表达升高,且这种诱导作用随暴露时间延长而增加,这表明COX-2或负责COX-2蛋白表达的信号转导途径可能在MMA(III)诱导的转化中起作用。急性暴露研究发现,MMA(III)处理(10、50和100nM,4小时)可诱导UROtsa细胞中的COX-2,其中最低剂量(10和50nM)诱导作用最强。使用各种途径的药理学抑制剂表明,表皮生长因子受体(EGFR)、细胞外信号调节激酶(ERK-1/-2)、磷脂酰肌醇3-激酶(PI3K)和src在MMA(III)诱导COX-2表达中起重要作用。通过蛋白质免疫印迹分析验证了ERK-2的磷酸化在15分钟时达到峰值,50nM MMA(III)处理后c-jun易位至细胞核。为了确定MMA(III)的靶点,进一步研究了成红细胞增多症致癌基因家族(ErbB)家族的受体。长期暴露于MMA(III)导致EGFR或ErbB1上调。短期MMA(III)处理导致ErbB2在其自身磷酸化位点发生磷酸化。为了验证这些信号通路对MMA(III)转化的UROtsa细胞在软琼脂中生长的重要性,使用了各种抑制剂来阻断通路并监测细胞生长。在长期暴露于MMA(III)的UROtsa细胞的非锚定依赖性生长中起重要作用的通路是src、PI3K以及COX-1和COX-2。由于COX-2是一种重要的介质,通过促进细胞增殖、抑制细胞死亡、诱导血管生成和促进侵袭来促进致癌作用,并且在MMA(III)转化的细胞中急性和慢性情况下均高度上调,因此丝裂原活化蛋白激酶途径的激活和COX-2表达的增加很可能是MMA(III)导致膀胱癌的合理机制。